Test Price
2,800 AED✅ Home Collection Available
NDP Gene Norrie Disease Genetic Test – Next Generation Sequencing in Dubai, UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-Accredited Next Generation Sequencing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (daily 8 AM to 11 PM).
- Clinical Guidance: Post-test telephonic consultation for result interpretation and family counseling.
- Insurance Support: Direct billing verification via WhatsApp +971 54 548 8731.
Clinical utility: Confirms pathogenic NDP mutations, establishes definitive Norrie disease diagnosis, and guides multidisciplinary management including ophthalmology, neurology, and genetic counseling.
Test Overview & Methodology
The NDP Gene Norrie Disease Genetic Test analyzes the Norrie Disease Pseudoglioma (NDP) gene using Next Generation Sequencing (NGS) with full gene coverage. This test is indicated for individuals presenting with congenital blindness, progressive neurological deterioration, or sensorineural hearing loss suggestive of Norrie disease. Results are interpreted by board-certified medical geneticists and delivered with a comprehensive clinical report.
| Feature | Our NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | Next Generation Sequencing (NGS) – full gene coverage | Sanger sequencing of individual exons |
| Sensitivity | >99.9% for single nucleotide variants & indels | ~95% for targeted mutations only |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks (if multiple exons needed) |
| Novel Variant Detection | Comprehensive – identifies rare or novel mutations | Limited to known regions |
Physician Insight & Safety Protocols
Genetic testing for Norrie disease must be interpreted alongside detailed clinical and family history. A positive NDP mutation confirms the diagnosis and enables early ophthalmologic, neurologic, and audiologic surveillance. A negative result does not fully exclude the condition; consider broader genetic workup if clinical suspicion remains high. Always consult a medical geneticist or genetic counselor for personalized risk assessment and recurrence risk counseling.
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Important Medication Advisory
Do not alter, pause, or discontinue any prescribed medication without first consulting your treating physician. Genetic test results may inform but do not replace ongoing clinical management.
Safety & Exclusion Criteria
- This test is not indicated for patients with unrelated neurological phenotypes not suggestive of NDP-related Norrie disease.
- Individuals with a known non-NDP genetic mutation should consider alternative, syndrome-specific testing.
- Emergency Red Flags: Sudden vision loss, acute neurological deterioration, or hearing loss after birth require immediate clinical evaluation – do not delay for genetic testing.
Patient FAQ & Clinical Guidance
1. What does a positive NDP gene result mean?
A positive result confirms a pathogenic or likely pathogenic mutation in the NDP gene, establishing a definitive diagnosis of Norrie disease. This guides early intervention including retinal monitoring, hearing assessments, neurological follow-up, and family cascade testing.
2. How long does it take to get results?
Results are typically available within 3 to 4 weeks from sample collection. This timeframe ensures thorough NGS analysis, bioinformatic interpretation, and expert clinical review by our genetics team.
3. Is home blood collection available in Dubai for this test?
Yes. Our VIP Mobile Phlebotomy service is available daily from 8 AM to 11 PM across all UAE emirates. Samples are transported under ISO-certified temperature-controlled cold-chain logistics to preserve DNA integrity.
4. Who should consider this genetic test?
This test is recommended for infants or children presenting with congenital blindness, progressive vision loss, developmental delay, or sensorineural hearing loss with a clinical suspicion of Norrie disease. It is also offered to families with a known NDP mutation for carrier testing and prenatal planning.
5. Does insurance cover this test?
Coverage varies by insurance provider and policy. Our team can verify direct billing eligibility via WhatsApp +971 54 548 8731. Self-pay options are also available at 2,800 AED.
UAE Regulatory & Data Privacy Adherence
All clinical genetic testing procedures at DNA Labs UAE comply with UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), ensuring your genetic data is encrypted, access-controlled, and never shared without explicit consent. Our health information systems adhere to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, guaranteeing secure digital storage and transmission of test results. Patient safety and informed consent protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability. Our laboratory is ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | NDP Gene Norrie Disease Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (Peripheral Venous Blood) |
| Methodology Used | Next Generation Sequencing (NGS) – Full Gene Coverage |
| ICD-10-CM Code | Q15.8 |
| LOINC Code | 51952-3 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians